577 related articles for article (PubMed ID: 34665953)
1. Crosstalk between tumor-associated macrophages and neighboring cells in hepatocellular carcinoma.
Sung PS
Clin Mol Hepatol; 2022 Jul; 28(3):333-350. PubMed ID: 34665953
[TBL] [Abstract][Full Text] [Related]
2. The role of tumor-associated macrophages in hepatocellular carcinoma progression: A narrative review.
Zhang X; Yu C; Zhao S; Wang M; Shang L; Zhou J; Ma Y
Cancer Med; 2023 Dec; 12(24):22109-22129. PubMed ID: 38098217
[TBL] [Abstract][Full Text] [Related]
3. Targeting tumor associated macrophages in hepatocellular carcinoma.
Xu W; Cheng Y; Guo Y; Yao W; Qian H
Biochem Pharmacol; 2022 May; 199():114990. PubMed ID: 35288152
[TBL] [Abstract][Full Text] [Related]
4. Construction of TME and Identification of crosstalk between malignant cells and macrophages by SPP1 in hepatocellular carcinoma.
Liu L; Zhang R; Deng J; Dai X; Zhu X; Fu Q; Zhang H; Tong Z; Zhao P; Fang W; Zheng Y; Bao X
Cancer Immunol Immunother; 2022 Jan; 71(1):121-136. PubMed ID: 34028567
[TBL] [Abstract][Full Text] [Related]
5. The inflammatory microenvironment in hepatocellular carcinoma: a pivotal role for tumor-associated macrophages.
Capece D; Fischietti M; Verzella D; Gaggiano A; Cicciarelli G; Tessitore A; Zazzeroni F; Alesse E
Biomed Res Int; 2013; 2013():187204. PubMed ID: 23533994
[TBL] [Abstract][Full Text] [Related]
6. Tumor-associated macrophages in liver cancer: From mechanisms to therapy.
Cheng K; Cai N; Zhu J; Yang X; Liang H; Zhang W
Cancer Commun (Lond); 2022 Nov; 42(11):1112-1140. PubMed ID: 36069342
[TBL] [Abstract][Full Text] [Related]
7. Crosstalk between hepatic tumor cells and macrophages via Wnt/β-catenin signaling promotes M2-like macrophage polarization and reinforces tumor malignant behaviors.
Yang Y; Ye YC; Chen Y; Zhao JL; Gao CC; Han H; Liu WC; Qin HY
Cell Death Dis; 2018 Jul; 9(8):793. PubMed ID: 30022048
[TBL] [Abstract][Full Text] [Related]
8. Tumor-associated macrophages promote cancer stem cell-like properties via transforming growth factor-beta1-induced epithelial-mesenchymal transition in hepatocellular carcinoma.
Fan QM; Jing YY; Yu GF; Kou XR; Ye F; Gao L; Li R; Zhao QD; Yang Y; Lu ZH; Wei LX
Cancer Lett; 2014 Oct; 352(2):160-8. PubMed ID: 24892648
[TBL] [Abstract][Full Text] [Related]
9. Repolarization of macrophages to improve sorafenib sensitivity for combination cancer therapy.
Huang L; Xu R; Li W; Lv L; Lin C; Yang X; Yao Y; Saw PE; Xu X
Acta Biomater; 2023 May; 162():98-109. PubMed ID: 36931417
[TBL] [Abstract][Full Text] [Related]
10. Cancer‑associated fibroblast‑induced M2‑polarized macrophages promote hepatocellular carcinoma progression via the plasminogen activator inhibitor‑1 pathway.
Chen S; Morine Y; Tokuda K; Yamada S; Saito Y; Nishi M; Ikemoto T; Shimada M
Int J Oncol; 2021 Aug; 59(2):. PubMed ID: 34195849
[TBL] [Abstract][Full Text] [Related]
11. miR-125a/b inhibits tumor-associated macrophages mediated in cancer stem cells of hepatocellular carcinoma by targeting CD90.
Wang Y; Wang B; Xiao S; Li Y; Chen Q
J Cell Biochem; 2019 Mar; 120(3):3046-3055. PubMed ID: 30536969
[TBL] [Abstract][Full Text] [Related]
12. Reciprocal interactions between malignant cells and macrophages enhance cancer stemness and M2 polarization in HBV-associated hepatocellular carcinoma.
Zhang Q; Tsui YM; Zhang VX; Lu AJ; Lee JM; Lee E; Cheung GC; Li PM; Cheung ET; Chia NH; Lo IL; Chan AC; Cheung TT; Ng IO; Ho DW
Theranostics; 2024; 14(2):892-910. PubMed ID: 38169544
[No Abstract] [Full Text] [Related]
13. Current Strategies for Modulating Tumor-Associated Macrophages with Biomaterials in Hepatocellular Carcinoma.
Liu Q; Huang W; Liang W; Ye Q
Molecules; 2023 Feb; 28(5):. PubMed ID: 36903458
[TBL] [Abstract][Full Text] [Related]
14. Promotion of epithelial-mesenchymal transformation by hepatocellular carcinoma-educated macrophages through Wnt2b/β-catenin/c-Myc signaling and reprogramming glycolysis.
Jiang Y; Han Q; Zhao H; Zhang J
J Exp Clin Cancer Res; 2021 Jan; 40(1):13. PubMed ID: 33407720
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-6 induced by YAP in hepatocellular carcinoma cells recruits tumor-associated macrophages.
Zhou TY; Zhou YL; Qian MJ; Fang YZ; Ye S; Xin WX; Yang XC; Wu HH
J Pharmacol Sci; 2018 Oct; 138(2):89-95. PubMed ID: 30340922
[TBL] [Abstract][Full Text] [Related]
16. Tumor-Associated Macrophages in Hepatocellular Carcinoma: Friend or Foe?
Zhou D; Luan J; Huang C; Li J
Gut Liver; 2021 Jul; 15(4):500-516. PubMed ID: 33087588
[TBL] [Abstract][Full Text] [Related]
17. Coculturing liver cancer cells and monocytes in spheroids conditions monocytes to adopt tumor-associated macrophage phenotypes that favor tumor growth via cholesterol metabolism.
Keawvilai P; Kueanjinda P; Klomsing J; Palaga T
J Leukoc Biol; 2024 Jan; 115(2):344-357. PubMed ID: 37742062
[TBL] [Abstract][Full Text] [Related]
18. S100 calcium-binding protein A9 from tumor-associated macrophage enhances cancer stem cell-like properties of hepatocellular carcinoma.
Wei R; Zhu WW; Yu GY; Wang X; Gao C; Zhou X; Lin ZF; Shao WQ; Wang SH; Lu M; Qin LX
Int J Cancer; 2021 Mar; 148(5):1233-1244. PubMed ID: 33205453
[TBL] [Abstract][Full Text] [Related]
19. IRE1α inhibition by natural compound genipin on tumour associated macrophages reduces growth of hepatocellular carcinoma.
Tan HY; Wang N; Tsao SW; Che CM; Yuen MF; Feng Y
Oncotarget; 2016 Jul; 7(28):43792-43804. PubMed ID: 27270308
[TBL] [Abstract][Full Text] [Related]
20. CD86⁺/CD206⁺, Diametrically Polarized Tumor-Associated Macrophages, Predict Hepatocellular Carcinoma Patient Prognosis.
Dong P; Ma L; Liu L; Zhao G; Zhang S; Dong L; Xue R; Chen S
Int J Mol Sci; 2016 Mar; 17(3):320. PubMed ID: 26938527
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
